A group of former executives from health communications firm Inizio Evoke have l...
Biogen has bolstered its research and development efforts by securing an agreeme...
The U.S. Food and Drug Administration (FDA) has approved Romvimza (vimseltinib) ...
The U.S. Food and Drug Administration (FDA) has approved Penmenvy, a vaccine for...
Bristol Myers Squibb has persisted with its aggressive cost-reduction strategy, ...
To forward a significant pipeline opportunity, Biogen has secured $250 million. ...
Following the recent statement by Merck KGaA that it is in advanced talks about ...
Abcuro, a biotechnology company backed by Sanofi, has secured $200 million in Se...
Sionna Therapeutics, a biotechnology firm headquartered in Waltham, Massachusett...
AdvanCell has raised $112 million in a Series C fundraising round supported by S...
Enhertu, the first antibody-drug conjugate (ADC) developed by AstraZeneca and Da...
Versant Ventures established Helicore Biopharma exactly two months after establi...
Atalanta Therapeutics has raised $97 million in a successful Series B financing ...
Leap Therapeutics has decided to redirect its efforts towards colorectal cancer ...
Disc Medicine has finalized the design for its confirmatory trial of bitopertin,...
Atara Biotherapeutics has now faced a second setback after getting a complete re...
